Kubota, Wataru
Honda, Masataka
Okada, Hirokazu
Hattori, Motoshi
Iwano, Masayuki
Akioka, Yuko
Ashida, Akira
Kawasaki, Yukihiko
Kiyomoto, Hideyasu
Sako, Mayumi
Terada, Yoshio
Hirano, Daishi
Fujieda, Mikiya
Fujimoto, Shouichi
Masaki, Takao
Ito, Shuichi
Uemura, Osamu
Gotoh, Yoshimitsu
Komatsu, Yasuhiro
Nishi, Shinichi
Maru, Mitsue
Narita, Ichiei
Maruyama, Shoichi
Article History
Received: 24 April 2018
Accepted: 11 May 2018
First Online: 4 June 2018
Compliance with ethical standards
:
: Hirokazu Okada has received honoraria from Kyowa Hakko Kirin Co., Ltd., Alexion Pharmaceuticals, Inc., and subsidies from Takeda Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Torii Pharmaceutical Co., Ltd., Kyowa Hakko Kirin Co., Ltd., Pfizer Japan Inc., Boehringer Ingelheim GmbH, Astellas Pharma Inc., Otsuka Pharmaceutical Co., Ltd., MSD K.K., Shionogi & Co., Ltd., Novartis Pharma K.K., Sumitomo Dainippon Co., Ltd., Mitsubishi Tanabe Pharma Co., and Daiichi Sankyo Co., Ltd. Masayuki Iwano has received honoraria from Otsuka Pharmaceutical Co., Ltd., and subsidies from Takeda Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Kyowa Hakko Kirin Co., Ltd., Pfizer Japan Inc., Astellas Pharma Inc., Otsuka Pharmaceutical Co., Ltd., Novartis Pharma K.K., Baxter Ltd., Sumitomo Dainippon Co., Ltd., Eli Lilly Japan K.K., and Mitsubishi Tanabe Pharma Co. Mayumi Sako has received consulting fees from Astellas Pharma Inc. and Zenyaku Kogyo Co., Ltd. Takao Masaki has received honoraria from Kyowa Hakko Kirin Co., Ltd. and subsidies from Takeda Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Torii Pharmaceutical Co., Ltd., Kyowa Hakko Kirin Co., Ltd., Otsuka Pharmaceutical Co., Ltd., JMS Co., Ltd., Mitsubishi Tanabe Pharma Co., Daiichi Sankyo Co., Ltd., Bayer Yakuhin Ltd., Baxter Ltd., Kaneka Medix Co., TERUMO CORPORATION, and Mochida Pharmaceutical Co., Ltd. Shuichi Ito has received honoraria from Alexion Pharmaceuticals, Inc. and Genzyme Japan K.K., and subsidies from Pfizer Japan Inc., Astellas Pharma Inc.